{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T06:49:17Z","timestamp":1793342957037,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"DOI":"10.1186\/s12987-026-00826-1","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:17:26Z","timestamp":1781018246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Estimation of human brain fluid clearance using intrathecal imaging contrast agents"],"prefix":"10.1186","volume":"23","author":[{"given":"Per Kristian","family":"Eide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aslan","family":"Lashkarivand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne S\u00f8rensen","family":"Hernes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir","family":"Ringstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Hovd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"826_CR1","doi-asserted-by":"publisher","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF Flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med. 2012;4(147):147ra111. https:\/\/doi.org\/10.1126\/scitranslmed.3003748.","DOI":"10.1126\/scitranslmed.3003748"},{"issue":"7560","key":"826_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523(7560):337\u201341. https:\/\/doi.org\/10.1038\/nature14432.","journal-title":"Nature"},{"issue":"7","key":"826_CR3","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1084\/jem.20142290","volume":"212","author":"A Aspelund","year":"2015","unstructured":"Aspelund A, Antila S, Proulx ST, Karlsen TV, Karaman S, Detmar M, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med. 2015;212(7):991\u201399. https:\/\/doi.org\/10.1084\/jem.20142290.","journal-title":"J Exp Med"},{"issue":"23","key":"826_CR4","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1016\/j.neuron.2025.10.036","volume":"113","author":"J Kipnis","year":"2025","unstructured":"Kipnis J, Benveniste H, Eichmann A, Thomas JL, Reich DS, Lewis LD, et al. Resolving the mysteries of brain clearance and immune surveillance. Neuron. 2025;113(23):3908\u201323. https:\/\/doi.org\/10.1016\/j.neuron.2025.10.036.","journal-title":"Neuron"},{"key":"826_CR5","doi-asserted-by":"publisher","unstructured":"Keil SA, Jansson D, Braun M, Iliff JJ. Glymphatic dysfunction in Alzheimer\u2019s disease: a critical appraisal. Science. 2025;389(6756):eadv 8269. https:\/\/doi.org\/10.1126\/science.adv8269.","DOI":"10.1126\/science.adv8269"},{"issue":"1","key":"826_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1146\/annurev-pharmtox-010716-104846","volume":"57","author":"CF Bennett","year":"2017","unstructured":"Bennett CF, Baker BF, Pham N, Swayze E, Geary RS. Pharmacology of Antisense drugs. Annu Rev Pharmacol Toxicol. 2017;57(1):81\u2013105. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010716-104846.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"826_CR7","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s13311-022-01247-2","volume":"19","author":"BD Boros","year":"2022","unstructured":"Boros BD, Schoch KM, Kreple CJ, Miller TM. Antisense oligonucleotides for the study and Treatment of ALS. Neurotherapeutics. 2022;19(4):1145\u201358. https:\/\/doi.org\/10.1007\/s13311-022-01247-2.","journal-title":"Neurotherapeutics"},{"issue":"6","key":"826_CR8","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.neuron.2017.04.010","volume":"94","author":"KM Schoch","year":"2017","unstructured":"Schoch KM, Miller TM. Antisense oligonucleotides: translation from mouse models to human neurodegenerative diseases. Neuron. 2017;94(6):1056\u201370. https:\/\/doi.org\/10.1016\/j.neuron.2017.04.010.","journal-title":"Neuron"},{"key":"826_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuropharm.2016.12.015","volume":"120","author":"KM Bishop","year":"2017","unstructured":"Bishop KM. Progress and promise of antisense oligonucleotide therapeutics for central nervous system diseases. Neuropharmacology. 2017;120:56\u201362. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.12.015.","journal-title":"Neuropharmacology"},{"key":"826_CR10","doi-asserted-by":"publisher","first-page":"114949","DOI":"10.1016\/j.addr.2023.114949","volume":"199","author":"R Ajeeb","year":"2023","unstructured":"Ajeeb R, Clegg JR. Intrathecal delivery of macromolecules: clinical status and emerging technologies. Adv Drug Deliv Rev. 2023;199:114949. https:\/\/doi.org\/10.1016\/j.addr.2023.114949.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"826_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"WM Pardridge","year":"2005","unstructured":"Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx: J The Am Soc Exp NeuroTherapeutics. 2005;2(1):3\u201314. https:\/\/doi.org\/10.1602\/neurorx.2.1.3.","journal-title":"NeuroRx: J The Am Soc Exp NeuroTherapeutics"},{"issue":"8","key":"826_CR12","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.apsb.2020.01.015","volume":"10","author":"W Chen","year":"2020","unstructured":"Chen W, Hu Y, Ju D. Gene therapy for neurodegenerative disorders: advances, insights and prospects. Acta Pharmaceutica Sin. B. 2020;10(8):1347\u201359. https:\/\/doi.org\/10.1016\/j.apsb.2020.01.015.","journal-title":"Acta Pharmaceutica Sin. B"},{"issue":"1","key":"826_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00415-018-9124-0","volume":"266","author":"CD Wurster","year":"2019","unstructured":"Wurster CD, Winter B, Wollinsky K, Ludolph AC, Uzelac Z, Witzel S, et al. Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients. J Neurol. 2019;266(1):183\u201394. https:\/\/doi.org\/10.1007\/s00415-018-9124-0.","journal-title":"J Neurol"},{"issue":"1","key":"826_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13046-019-1180-5","volume":"38","author":"GED Petrescu","year":"2019","unstructured":"Petrescu GED, Sabo AA, Torsin LI, Calin GA, Dragomir MP. MicroRNA based theranostics for brain cancer: basic principles. J Exp Clin Cancer Res. 2019;38(1):231. https:\/\/doi.org\/10.1186\/s13046-019-1180-5.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"826_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-019-0664-z","volume":"7","author":"S Jadhav","year":"2019","unstructured":"Jadhav S, Avila J, Sch\u00f6ll M, Kovacs GG, K\u00f6vari E, Skrabana R, et al. A walk through tau therapeutic strategies. Acta Neuropathol Commun. 2019;7(1):22. https:\/\/doi.org\/10.1186\/s40478-019-0664-z.","journal-title":"Acta Neuropathol Commun"},{"key":"826_CR16","doi-asserted-by":"publisher","unstructured":"Chen Y, Mazur C, Luo Y, Sun L, Zhang M, McCampbell A, et al. Intrathecal delivery of Antisense oligonucleotides in the rat central nervous system. JoVe. 2019;(152). https:\/\/doi.org\/10.3791\/60274.","DOI":"10.3791\/60274"},{"issue":"20","key":"826_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1172\/jci.insight.129240","volume":"4","author":"C Mazur","year":"2019","unstructured":"Mazur C, Powers B, Zasadny K, Sullivan JM, Dimant H, Kamme F, et al. Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging. JCI Insight. 2019;4(20):4. https:\/\/doi.org\/10.1172\/jci.insight.129240.","journal-title":"JCI Insight"},{"issue":"10063","key":"826_CR18","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","volume":"388","author":"RS Finkel","year":"2016","unstructured":"Finkel RS, Chiriboga CA, Vajsar J, Day JW, Montes J, De Vivo DC, et al. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study. Lancet. 2016;388(10063):3017\u201326. https:\/\/doi.org\/10.1016\/S0140-6736(16)31408-8.","journal-title":"Lancet"},{"key":"826_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/4047617","volume":"2019","author":"DM Byrnes","year":"2019","unstructured":"Byrnes DM, Vargas F, Dermarkarian C, Kahn R, Kwon D, Hurley J, et al. Complications of intrathecal chemotherapy in adults: single-institution experience in 109 consecutive patients. J Oncol. 2019;2019:1\u20137. https:\/\/doi.org\/10.1155\/2019\/4047617.","journal-title":"J Oncol"},{"issue":"1","key":"826_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.emc.2013.09.002","volume":"32","author":"Z Livshits","year":"2014","unstructured":"Livshits Z, Rao RB, Smith SW. An approach to chemotherapy-associated toxicity. Emerg Med Clin N Am. 2014;32(1):167\u2013203. https:\/\/doi.org\/10.1016\/j.emc.2013.09.002.","journal-title":"Emerg Med Clin N Am"},{"key":"826_CR21","doi-asserted-by":"publisher","unstructured":"Nguyen AD, Nguyen TA, Zhang J, Devireddy S, Zhou P, Karydas AM, et al. Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decay. Proc Natl Acad Sci USA. 2018;115(12):E2849\u2013e 2858. https:\/\/doi.org\/10.1073\/pnas.1722344115.","DOI":"10.1073\/pnas.1722344115"},{"issue":"8","key":"826_CR22","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1172\/JCI99081","volume":"128","author":"A McCampbell","year":"2018","unstructured":"McCampbell A, Cole T, Wegener AJ, Tomassy GS, Setnicka A, Farley BJ, et al. Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. J Clin Investigation. 2018;128(8):3558\u201367. https:\/\/doi.org\/10.1172\/JCI99081.","journal-title":"J Clin Investigation"},{"issue":"465","key":"826_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1126\/scitranslmed.aap8677","volume":"10","author":"C Niu","year":"2018","unstructured":"Niu C, Prakash TP, Kim A, Quach JL, Huryn LA, Yang Y, et al. Antisense oligonucleotides targeting mutant ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7. Sci Transl Med. 2018;10(465):10. https:\/\/doi.org\/10.1126\/scitranslmed.aap8677.","journal-title":"Sci Transl Med"},{"issue":"3","key":"826_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/14712598.2018.1416089","volume":"18","author":"N Hardcastle","year":"2018","unstructured":"Hardcastle N, Boulis NM, Federici T. AAV gene delivery to the spinal cord: serotypes, methods, candidate diseases, and clinical trials. Expert Opin Biol Ther. 2018;18(3):293\u2013307. https:\/\/doi.org\/10.1080\/14712598.2018.1416089.","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"826_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12987-022-00352-w","volume":"19","author":"MH Hovd","year":"2022","unstructured":"Hovd MH, Mariussen E, Uggerud H, Lashkarivand A, Christensen H, Ringstad G, et al. Population pharmacokinetic modeling of CSF to blood clearance: prospective tracer study of 161 patients under work-up for CSF disorders. Fluids Barriers CNS. 2022;19(1):55. https:\/\/doi.org\/10.1186\/s12987-022-00352-w.","journal-title":"Fluids Barriers CNS"},{"issue":"13","key":"826_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.121537","volume":"3","author":"G Ringstad","year":"2018","unstructured":"Ringstad G, Valnes LM, Dale AM, Pripp AH, Vatnehol S-AS, Emblem KE, et al. Brain-wide glymphatic enhancement and clearance in humans assessed with MRI. JCI Insight. 2018;3(13):1\u201316. https:\/\/doi.org\/10.1172\/jci.insight.121537.","journal-title":"JCI Insight"},{"issue":"23","key":"826_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.173276","volume":"8","author":"E Melin","year":"2023","unstructured":"Melin E, Pripp AH, Eide PK, Ringstad G. In vivo distribution of cerebrospinal fluid tracer in human upper spinal cord and brain stem. JCI Insight. 2023;8(23):1\u201314. https:\/\/doi.org\/10.1172\/jci.insight.173276.","journal-title":"JCI Insight"},{"issue":"9","key":"826_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1172\/jci.insight.147063","volume":"6","author":"PK Eide","year":"2021","unstructured":"Eide PK, Mariussen E, Uggerud H, Pripp AH, Lashkarivand A, Hassel B, et al. Clinical application of intrathecal gadobutrol for assessment of cerebrospinal fluid tracer clearance to blood. JCI Insight. 2021;6(9):6. https:\/\/doi.org\/10.1172\/jci.insight.147063.","journal-title":"JCI Insight"},{"issue":"9","key":"826_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.147063","volume":"6","author":"PK Eide","year":"2021","unstructured":"Eide PK, Mariussen E, Uggerud H, Pripp AH, Lashkarivand A, Hassel B, et al. Clinical application of intrathecal gadobutrol for assessment of cerebrospinal fluid tracer clearance to blood. JCI Insight. 2021;6(9):1\u201313. https:\/\/doi.org\/10.1172\/jci.insight.147063.","journal-title":"JCI Insight"},{"key":"826_CR30","doi-asserted-by":"publisher","unstructured":"van Osch Mjp, W\u00e5hlin A, Scheyhing P, Mossige I, Hirschler L, Eklund A, et al. Human brain clearance imaging: pathways taken by magnetic resonance imaging contrast agents after administration in cerebrospinal fluid and blood. NMR Biomed. 2024;37(9):e 5159. https:\/\/doi.org\/10.1002\/nbm.5159.","DOI":"10.1002\/nbm.5159"},{"issue":"4","key":"826_CR31","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/FTD.0b013e31825c4ba6","volume":"34","author":"MN Neely","year":"2012","unstructured":"Neely MN, van Guilder MG, Yamada WM, Schumitzky A, Jelliffe RW. Accurate detection of outliers and subpopulations with pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R. Ther Drug Monit. 2012;34(4):467\u201376. https:\/\/doi.org\/10.1097\/FTD.0b013e31825c4ba6.","journal-title":"Ther Drug Monit"},{"issue":"1","key":"826_CR32","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1038\/s41467-024-46329-1","volume":"15","author":"PK Eide","year":"2024","unstructured":"Eide PK, Ringstad G. Functional analysis of the human perivascular subarachnoid space. Nat Commun. 2024;15(1):2001. https:\/\/doi.org\/10.1038\/s41467-024-46329-1.","journal-title":"Nat Commun"},{"issue":"1","key":"826_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12987-025-00679-0","volume":"22","author":"PK Eide","year":"2025","unstructured":"Eide PK, Hovd M, Pripp A, Gjertsen \u00d8, L\u00f8vland G, Lashkarivand A, et al. Altered brain fluid dynamics in spontaneous intracranial hypotension. Fluids Barriers CNS. 2025;22(1):65. https:\/\/doi.org\/10.1186\/s12987-025-00679-0.","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"826_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","volume":"139","author":"AS Levey","year":"2003","unstructured":"Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137\u201347. https:\/\/doi.org\/10.7326\/0003-4819-139-2-200307150-00013.","journal-title":"Ann Intern Med"},{"issue":"1","key":"826_CR35","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1038\/s41467-023-37685-5","volume":"14","author":"PK Eide","year":"2023","unstructured":"Eide PK, Lashkarivand A, Pripp A, Valnes LM, Hovd MH, Ringstad G, et al. Plasma neurodegeneration biomarker concentrations associate with glymphatic and meningeal lymphatic measures in neurological disorders. Nat Commun. 2023;14(1):2084. https:\/\/doi.org\/10.1038\/s41467-023-37685-5.","journal-title":"Nat Commun"},{"issue":"1","key":"826_CR36","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s42003-023-04634-3","volume":"6","author":"E Melin","year":"2023","unstructured":"Melin E, Ringstad G, Valnes LM, Eide PK. Human parasagittal dura is a potential neuroimmune interface. Commun Biol. 2023;6(1):260. https:\/\/doi.org\/10.1038\/s42003-023-04634-3.","journal-title":"Commun Biol"},{"issue":"4","key":"826_CR37","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1177\/0271678X251386232","volume":"46","author":"B Falkenberg-Jensen","year":"2026","unstructured":"Falkenberg-Jensen B, Pripp AH, Ringstad G, Eide PK. Cranial nerves as pathways for human cerebrospinal fluid efflux: in vivo evidence. J Cereb Blood Flow Metab. 2026;46(4):913\u201323. https:\/\/doi.org\/10.1177\/0271678X251386232.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"826_CR38","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1038\/s41467-019-12568-w","volume":"10","author":"L Jacob","year":"2019","unstructured":"Jacob L, Boisserand LSB, Geraldo LHM, de Brito Neto J, Mathivet T, Antila S, et al. Anatomy and function of the vertebral column lymphatic network in mice. Nat Commun. 2019;10(1):4594. https:\/\/doi.org\/10.1038\/s41467-019-12568-w.","journal-title":"Nat Commun"},{"issue":"1","key":"826_CR39","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41467-019-14195-x","volume":"11","author":"G Ringstad","year":"2020","unstructured":"Ringstad G, Eide PK. Cerebrospinal fluid tracer efflux to parasagittal dura in humans. Nat Commun. 2020;11(1):354. https:\/\/doi.org\/10.1038\/s41467-019-14195-x.","journal-title":"Nat Commun"},{"issue":"10","key":"826_CR40","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1093\/brain\/awx191","volume":"140","author":"G Ringstad","year":"2017","unstructured":"Ringstad G, Vatnehol SAS, Eide PK. Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain. 2017;140(10):2691\u2013705. https:\/\/doi.org\/10.1093\/brain\/awx191.","journal-title":"Brain"},{"issue":"7","key":"826_CR41","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1177\/0271678X18760974","volume":"39","author":"PK Eide","year":"2019","unstructured":"Eide PK, Ringstad G. Delayed clearance of cerebrospinal fluid tracer from entorhinal cortex in idiopathic normal pressure hydrocephalus: a glymphatic magnetic resonance imaging study. J Cereb Blood Flow Metab. 2019;39(7):1355\u201368. https:\/\/doi.org\/10.1177\/0271678X18760974.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"826_CR42","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1093\/brain\/awab388","volume":"145","author":"G Ringstad","year":"2022","unstructured":"Ringstad G, Eide PK. Molecular trans-dural efflux to skull bone marrow in humans with CSF disorders. Brain. 2022;145(4):1464\u201372. https:\/\/doi.org\/10.1093\/brain\/awab388.","journal-title":"Brain"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-026-00826-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00826-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00826-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:22:45Z","timestamp":1781076165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12987-026-00826-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["826"],"URL":"https:\/\/doi.org\/10.1186\/s12987-026-00826-1","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical standards in line with the Declaration of Helsinki (1975, revised in 1983) were strictly followed. The Regional Committee for Medical and Health Research Ethics of Health, Southeast Region, Norway, approved both the study using intrathecal iodixanol and blood sampling (approval 266464) and the study using intrathecal gadobutrol and blood sampling (approval 2015\/96; 26344). Written and oral informed consent was provided by all patients prior to inclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The data protection officer of Oslo University Hospital approved the study using intrathecal iodixanol and blood sampling (approval 21\/14081) and the study using intrathecal gadobutrol and blood sampling (2015\/1868). The study using intrathecal gadobutrol was also approved by the National Medicines Agency, Norway (15\/04932\u20137; new approval number EU CT 2024-519936-18\u201300).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Regulatory approvals"}},{"value":"A.L., S.S.H. and M.H. have declared that no conflict of interest exists; PKE and GR are shareholders in BrainWideSolutions AS, Oslo, Norway, which is a holder of patents US 11,272,841 and US 12,016,651-B2.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}